Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells.

Standard

Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells. / Sputtek, Andreas; Lioznov, Michael; Kröger, Nicolaus; Rowe, Arthur W.

In: CYTOTHERAPY, Vol. 13, No. 4, 4, 2011, p. 481-489.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{72df83d5244b477686b632b738f93513,
title = "Bioequivalence comparison of a new freezing bag (CryoMACS({\textregistered})) with the Cryocyte({\textregistered}) freezing bag for cryogenic storage of human hematopoietic progenitor cells.",
abstract = "Abstract Background aims. We investigated two different plastic freezing bags, namely the most recently U.S. Food and Drug Administration (FDA)-approved CryoMACS({\textregistered}) freezing bag (200-074-402) from Miltenyi Biotec and the familiar Cryocyte({\textregistered}) freezing bag (R4R9955) from (Baxter Healthcare, Deerfield, IL, United States) for the cryogenic storage of human hematopoietic progenitor cells (HPC). Methods. The study material consisted of 12 frozen HPC pairs (= 24 transplant units) that were no longer needed for autologous treatment of patients. After thawing, one unit of a pair was transferred into the Miltenyi (M) bag; the other unit remained in the original Baxter (B) bag. After refreezing both units, all units were stored again under cryogenic conditions either partially immersed in liquid nitrogen (n = 22) or in the vapor phase over liquid nitrogen, n = 2,",
author = "Andreas Sputtek and Michael Lioznov and Nicolaus Kr{\"o}ger and Rowe, {Arthur W}",
year = "2011",
language = "Deutsch",
volume = "13",
pages = "481--489",
journal = "CYTOTHERAPY",
issn = "1465-3249",
publisher = "informa healthcare",
number = "4",

}

RIS

TY - JOUR

T1 - Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells.

AU - Sputtek, Andreas

AU - Lioznov, Michael

AU - Kröger, Nicolaus

AU - Rowe, Arthur W

PY - 2011

Y1 - 2011

N2 - Abstract Background aims. We investigated two different plastic freezing bags, namely the most recently U.S. Food and Drug Administration (FDA)-approved CryoMACS(®) freezing bag (200-074-402) from Miltenyi Biotec and the familiar Cryocyte(®) freezing bag (R4R9955) from (Baxter Healthcare, Deerfield, IL, United States) for the cryogenic storage of human hematopoietic progenitor cells (HPC). Methods. The study material consisted of 12 frozen HPC pairs (= 24 transplant units) that were no longer needed for autologous treatment of patients. After thawing, one unit of a pair was transferred into the Miltenyi (M) bag; the other unit remained in the original Baxter (B) bag. After refreezing both units, all units were stored again under cryogenic conditions either partially immersed in liquid nitrogen (n = 22) or in the vapor phase over liquid nitrogen, n = 2,

AB - Abstract Background aims. We investigated two different plastic freezing bags, namely the most recently U.S. Food and Drug Administration (FDA)-approved CryoMACS(®) freezing bag (200-074-402) from Miltenyi Biotec and the familiar Cryocyte(®) freezing bag (R4R9955) from (Baxter Healthcare, Deerfield, IL, United States) for the cryogenic storage of human hematopoietic progenitor cells (HPC). Methods. The study material consisted of 12 frozen HPC pairs (= 24 transplant units) that were no longer needed for autologous treatment of patients. After thawing, one unit of a pair was transferred into the Miltenyi (M) bag; the other unit remained in the original Baxter (B) bag. After refreezing both units, all units were stored again under cryogenic conditions either partially immersed in liquid nitrogen (n = 22) or in the vapor phase over liquid nitrogen, n = 2,

M3 - SCORING: Zeitschriftenaufsatz

VL - 13

SP - 481

EP - 489

JO - CYTOTHERAPY

JF - CYTOTHERAPY

SN - 1465-3249

IS - 4

M1 - 4

ER -